Home › Cerebral Hemorrhage › Massachusetts › Boston
Cerebral Hemorrhage clinical trials in Boston, MA
6 studies for Cerebral Hemorrhage are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
RecruitingPhase 3
- Massachusetts General Hospital, Boston
Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation
Recruiting
- Beth Israel Deaconess Medical Center, Boston
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RecruitingObservational study
- Massachusetts General Hospital, Boston
- Boston Medical Center, Boston
Testing the Effectiveness of a Novel Intervention to Improve Medication Adherence in Stroke Survivors
Recruiting
- Massachusetts General Hospital, Boston
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
RecruitingPhase 3
- Tufts Medical Center, Boston
- Massachusetts General Hospital, Boston
- Boston Medical Center, Boston
- and 1 more
Statins In Intracerbral Hemorrhage
RecruitingPhase 3
- Beth Israel Deaconess Medical Center, Boston
Cerebral Hemorrhage trials in other cities
- New York City, NY10 studies
- Miami, FL9 studies
- Chicago, IL7 studies
- Columbus, OH5 studies
- Philadelphia, PA5 studies
- St. Louis, MO5 studies
- Sacramento, CA4 studies
- Houston, TX4 studies
- Atlanta, GA4 studies
- Jacksonville, FL4 studies
- Salt Lake City, UT4 studies
- Portland, OR4 studies
Other studies in Boston
- Breast Cancer110 studies
- Cancer (all types)90 studies
- Non-Small Cell Lung Cancer87 studies
- Lung Cancer63 studies
- Colorectal Cancer62 studies
- Ovarian Cancer62 studies
- Metastatic Cancer61 studies
- Prostate Cancer56 studies
- Endometrial Cancer51 studies
- Depression50 studies
- Heart Failure46 studies
- Multiple Myeloma45 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.